Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Tharos who wrote (6537)	6/23/1998 9:02:00 AM
From: LarryS	Read Replies (2) \| Respond to of 17367

I thought the adults might have been given Neuprex since they were brought into the same hospitals as the trials....but after rereading your post it looks like the adult trial is in different hospitals than those running the trials on the kids. Will the results from these ten patients be used to set up another Phase II & III trials on down the road?

To: Tharos who wrote (6537)	6/23/1998 11:11:00 AM
From: aknahow	Read Replies (2) \| Respond to of 17367

Tharos, I think it is interesting that the F.D.A. said go ahead and test this on adults. Do they have serious doubts that it does not work in kids? O.K. does not work in kids let XOMA try it in adults. Does not seem logical unless the English and the FDA feel there is at least a good indication that Neuprex helps, so try it on some adults, save some lives and get some useful additional data. Just my thoughts. I do not know the real reason why the F.D.A. approved expansion of the trial or a new trial with adults. It is Ellen's fault I don't know! <g>